People

Genfit, with offices in Lille, France and Cambridge, Mass., launched its initial public offering (IPO) on the Nasdaq on March 27. Dean Hum, chief operating officer of Genfit, took time out to speak with BioSpace about the company, the IPO and elafibranor.
BioSpace takes a quick look at some of the news coming from biotech and pharma companies from across Europe and Asia.
The median salaries for Alexion employees increased to nearly $224,000 in 2018. The previous year the median salary was $167,000.
Numerous top biopharma executives met recently in Manalapan, Florida for the R&D Leadership Summit. Although a wide range of topics were discussed, certain areas rose to the top as being of particular concern to industry leadership. Here’s a look at a few of those concerns.
Duke University has agreed to pay the U.S. government more than $112 million to settle allegations that a university-associated researcher falsified claims in order to obtain funding from the National Institutes of Health and other federal agencies.
Clinical Network Services USA, an integrated services group focused on clinical product development and subsidiary of Asia-Pacific specialist CRO Novotech, announced the appointment of Dr Robert Malone as Principal Consultant in its Washington D.C. office.
Karolinska Development’s portfolio company Aprea Therapeutics announces that Dr. Eyal C. Attar has been appointed to a position as Senior Vice President and Chief Medical Officer (CMO).
AbbVie is providing a promising future to the town of North Chicago. The pharma company has donated $40 million to build a brand new middle school for the community.
Both Bayer and J&J claim the lawsuits are without merit but believe that the $775 million settlement will allow the companies to move on from costly litigation.
The study will focus on whether or not treatment with progesterone will counter-act the first dose of a chemical-induced abortion medication.
PRESS RELEASES